CLOSE

Benchmark Investments

ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)

very highequitypharma & health care
37.70 0.38(1.02%) NAV as on 22 Nov 2024
-0.95 % 1 M
46.52 % 1 Y
24.42 % 3 Y

Growth Chart of the Scheme vis a vis benchmark

  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y

SCHEME DETAILS

Expenses Ratio :

1.92

As on 31 Oct, 2024
Age :

6 yrs 4 m

Since 13 07 ,2018
Exit Load :

1%

AUM :

5,024.00 Crs

Portfolio Price To Book Value :

6.42

Investing Style :

Large Growth

Min. Investment :

SIP 100 & Lumpsum 5000

Category :

sector funds

Fund Manager :

Dharmesh Kakkad

Launch Date :

13-Jul-18

Scheme Benchmark :

NA

FUND OBJECTIVE

To generate long-term capital appreciation by creating a portfolio that is invested in Equity and Equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.However there can be no assurance that the investment objectives of the scheme will be realized.

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

LATEST ASSET & PORTFOLIO ALLOCATION

as on Oct 31 ,2024
Others 2.13 %
Equity 97.87 %

TOP HOLDINGS

Sun Pharmaceutical Industries...14.35 %
Dr. Reddy's Laboratories Ltd.9.03 %
Cipla Ltd.8.07 %
Lupin Ltd.4.59 %
Aurobindo Pharma Ltd.4.57 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs76.16
Hospital & Healthcare Services16.21
Business Support3.28
Chemicals1.32
Insurance0.89
See All Sectors

5-YEARS HISTORY

Financial Year2019-20202020-20212021-20222022-20232023-2024
NAV in Rs (as on 31-Mar-2024)9.5417.3519.6918.6430.20
Net Assets(Rs Crores) (as on 31-Mar-2024) 1073.47 2213.63 2500.42 2594.59 3772.32
Scheme Returns(%)(Absolute)-6.3883.7912.51-5.3861.15
B'mark Returns(%)(Absolute)NANANANANA
Category Rank15/7519/7547/7563/7612/90

Quarterly Performance - Last 5 Years (Absolute Ret. In %)

Financial Year Q1 Q2 Q3 Q4
2024-20256.6621.11NANA
2023-202416.9511.7911.1611.48
2022-2023-8.796.630.10-2.76
2021-202217.814.01-1.46-6.01
2020-202137.1122.3210.75-2.09

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity37.700.38(1.02%)NAV As on 22 Nov, 202413-Jul-2018Inception Date5,024.00AUM In Cr.46.52%1Y24.42%3Y30.00%5Y23.17%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity417.413.07(0.74%)NAV As on 22 Nov, 202414-Jul-1999Inception Date3,416.13AUM In Cr.43.05%1Y24.32%3Y28.73%5Y16.59%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity29.820.33(1.13%)NAV As on 22 Nov, 202428-Dec-2015Inception Date1,208.05AUM In Cr.38.56%1Y20.56%3Y26.40%5Y13.05%Since Inception
Nippon India Pharma Fund(G)Very HighEquity506.595.71(1.14%)NAV As on 22 Nov, 202405-Jun-2004Inception Date8,688.65AUM In Cr.35.22%1Y19.48%3Y27.43%5Y21.13%Since Inception

BENCHMARK INVESTMENTS

Benchmark Investments, 6 Sector II Shanti Niketan, Govindpura Bhopal, Bhopal-462023, India. +91-755-4938282/+91-9826310337 hello@benchmarkinvestments.in.
Downloads
Quick Links
Useful Links

Mutual fund and other investments are always subject to market risks. Please read all, Scheme Information Documents (SID), Key Information Memorandum (KIM), Addendums(if any) issued there to from time to time and any other related documents or information carefully before investing. Past performance is not indicative or assurance of future performance or returns. Please consider your specific investment requirements before choosing a fund.

For any grievances, investors can contact at: hello@benchmarkinvestments.in,  Tel: +91-755-4938282 / +91-9826310337.
©  Copyrights 2022 , Benchmark Investments | All Rights Reserved |  Designed, Developed & Content Powered by Accord Fintech Pvt Ltd